A phase 2 uncontrolled, open-label study of intranasal BPL-003 (5-methoxy- N,N -dimethyltryptamine) in patients with treatment-resistant depression
1. 文件大小不能超过300M, 允许上传文档或压缩包等
2. 请确保上传文献的真实性、完整性,不得对原文做任何修改
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: https://doi.org/10.1177/02698811261420087
文献链接: https://journals.sagepub.com/doi/10.1177/02698811261420087
其他信息:
出版社: SAGE Publications
作者: Claire Roberts; Mathieu Seynaeve; Anna O. Ermakova; Fiona Dunbar; Hattie Wells; Adeep Puri; Catherine Bird; James J. Rucker
全文下载地址: https://journals.sagepub.com/doi/pdf/10.1177/02698811261420087

